Procter & Gamble (PG) | Financial Analysis & Statements
Procter & Gamble Co. Mega-cap Consumer Defensive
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
22.2B
Gross Profit
11.4B
51.22%
Operating Income
5.4B
24.16%
Net Income
4.3B
19.50%
EPS (Diluted)
$1.78
Balance Sheet Metrics
Total Assets
127.3B
Total Liabilities
74.0B
Shareholders Equity
53.3B
Debt to Equity
1.39
Cash Flow Metrics
Operating Cash Flow
5.0B
Free Cash Flow
3.8B
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Procter & Gamble Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 84.3B | 84.0B | 82.0B | 80.2B | 76.1B |
| Cost of Goods Sold | 41.2B | 40.8B | 42.8B | 42.2B | 37.1B |
| Gross Profit | 43.1B | 43.2B | 39.2B | 38.0B | 39.0B |
| Gross Margin % | 51.2% | 51.4% | 47.9% | 47.4% | 51.2% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 22.7B | 23.3B | 21.1B | 20.2B | 21.0B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 22.7B | 23.3B | 21.1B | 20.2B | 21.0B |
| Operating Income | 20.5B | 19.9B | 18.1B | 17.8B | 18.0B |
| Operating Margin % | 24.3% | 23.7% | 22.1% | 22.2% | 23.6% |
| Non-Operating Items | |||||
| Interest Income | 469.0M | 473.0M | 307.0M | 51.0M | 45.0M |
| Interest Expense | 907.0M | 925.0M | 756.0M | 439.0M | 502.0M |
| Other Non-Operating Income | 154.0M | -673.0M | 668.0M | 570.0M | 86.0M |
| Pre-tax Income | 20.2B | 18.8B | 18.4B | 18.0B | 17.6B |
| Income Tax | 4.1B | 3.8B | 3.6B | 3.2B | 3.3B |
| Effective Tax Rate % | 20.3% | 20.2% | 19.7% | 17.8% | 18.5% |
| Net Income | 16.1B | 15.0B | 14.7B | 14.8B | 14.4B |
| Net Margin % | 19.1% | 17.8% | 18.0% | 18.4% | 18.9% |
| Key Metrics | |||||
| EBITDA | 23.9B | 23.9B | 21.8B | 21.2B | 20.9B |
| EPS (Basic) | $6.67 | $6.18 | $6.07 | $6.00 | $5.69 |
| EPS (Diluted) | $6.51 | $6.02 | $5.90 | $5.81 | $5.50 |
| Basic Shares Outstanding | 2394902549 | 2407605178 | 2368200000 | 2457000000 | 2514235501 |
| Diluted Shares Outstanding | 2394902549 | 2407605178 | 2368200000 | 2457000000 | 2514235501 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Procter & Gamble Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 9.6B | 9.5B | 8.2B | 7.2B | 10.3B |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 6.2B | 6.1B | 5.5B | 5.1B | 4.7B |
| Inventory | 7.6B | 7.0B | 7.1B | 6.9B | 6.0B |
| Other Current Assets | 2.1B | 2.1B | 1.9B | 2.4B | 2.1B |
| Total Current Assets | 25.4B | 24.7B | 22.6B | 21.7B | 23.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0 | 1.0M | 0 | 0 | 0 |
| Goodwill | 105.2B | 102.7B | 105.1B | 103.1B | 105.5B |
| Intangible Assets | 21.9B | 22.0B | 23.8B | 23.7B | 23.6B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 12.4B | 13.2B | 11.8B | 11.0B | 10.0B |
| Total Non-Current Assets | 99.8B | 97.7B | 98.2B | 95.6B | 96.2B |
| Total Assets | 125.2B | 122.4B | 120.8B | 117.2B | 119.3B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 15.2B | 15.4B | 14.6B | 14.9B | 13.7B |
| Short-term Debt | 9.8B | 7.4B | 10.5B | 8.8B | 9.1B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 3.5B | 3.0B | 3.5B | 2.9B | 3.1B |
| Total Current Liabilities | 36.1B | 33.6B | 35.8B | 33.1B | 33.1B |
| Non-Current Liabilities | |||||
| Long-term Debt | 25.7B | 25.9B | 25.0B | 23.4B | 23.7B |
| Deferred Tax Liabilities | 5.8B | 6.5B | 6.5B | 6.8B | 6.2B |
| Other Non-Current Liabilities | 566.0M | 557.0M | 530.0M | 490.0M | 579.0M |
| Total Non-Current Liabilities | 36.9B | 38.2B | 38.0B | 37.3B | 39.5B |
| Total Liabilities | 72.9B | 71.8B | 73.8B | 70.4B | 72.7B |
| Equity | |||||
| Common Stock | 4.0B | 4.0B | 4.0B | 4.0B | 4.0B |
| Retained Earnings | 130.0B | 123.8B | 118.2B | 112.4B | 106.4B |
| Treasury Stock | 138.7B | 133.4B | 129.7B | 123.4B | 115.0B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 52.3B | 50.6B | 47.1B | 46.9B | 46.7B |
| Key Metrics | |||||
| Total Debt | 35.5B | 33.4B | 35.4B | 32.3B | 32.8B |
| Working Capital | -10.7B | -8.9B | -13.1B | -11.4B | -10.0B |
Balance Sheet Composition
Procter & Gamble Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 16.1B | 15.0B | 14.7B | 14.8B | 14.4B |
| Depreciation & Amortization | 2.8B | 2.9B | 2.7B | 2.8B | 2.7B |
| Stock-Based Compensation | 476.0M | 562.0M | 545.0M | 528.0M | 540.0M |
| Working Capital Changes | -821.0M | -436.0M | -1.2B | -1.1B | 371.0M |
| Operating Cash Flow | 17.1B | 18.7B | 16.9B | 16.8B | 17.9B |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | -11.0M | -21.0M | -765.0M | -1.4B | -34.0M |
| Investment Purchases | - | - | - | 0 | -55.0M |
| Investment Sales | - | - | - | 3.0M | 0 |
| Investing Cash Flow | -45.0M | -182.0M | -438.0M | -1.3B | -102.0M |
| Financing Activities | |||||
| Share Repurchases | -6.5B | -5.0B | -7.4B | -10.0B | -11.0B |
| Dividends Paid | -9.9B | -9.3B | -9.0B | -8.8B | -8.3B |
| Debt Issuance | 2.2B | 3.2B | 4.0B | 4.4B | 4.4B |
| Debt Repayment | -9.6B | -10.0B | -18.2B | -13.8B | -16.0B |
| Financing Cash Flow | -23.4B | -24.4B | -29.8B | -28.4B | -34.2B |
| Free Cash Flow | 14.0B | 16.5B | 13.8B | 13.6B | 15.6B |
| Net Change in Cash | -6.4B | -5.9B | -13.3B | -12.8B | -16.4B |
Cash Flow Trend
Procter & Gamble Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
21.55
Forward P/E
20.23
Price to Book
6.48
Price to Sales
3.99
PEG Ratio
-3.48
Profitability Ratios
Profit Margin
19.30%
Operating Margin
26.30%
Return on Equity
31.56%
Return on Assets
10.90%
Financial Health
Current Ratio
0.72
Debt to Equity
68.72
Beta
0.40
Per Share Data
EPS (TTM)
$6.76
Book Value per Share
$22.49
Revenue per Share
$36.40
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| PG | 340.5B | 21.55 | 6.48 | 31.56% | 19.30% | 68.72 |
| Colgate-Palmolive | 67.9B | 31.83 | 1,249.55 | 497.47% | 10.46% | 2,343.56 |
| Kimberly-Clark | 47.7B | 19.60 | 43.35 | 207.06% | 12.48% | 595.10 |
| Kenvue | 33.6B | 22.78 | 3.08 | 14.39% | 9.72% | 80.58 |
| Estee Lauder | 28.1B | 124.05 | 6.94 | -4.34% | -1.21% | 232.95 |
| Church & Dwight | 22.5B | 31.32 | 5.59 | 17.62% | 11.88% | 59.52 |
Financial data is updated regularly. All figures are in the company's reporting currency.






